Pediatric low-grade gliomas: Prognosis with proton magnetic resonance spectroscopic imaging

Neurosurgery

Volumn 43, Issue 4, 1998, Pages 809-817

  Lazareff, Jorge A ^a,b   Bockhorst, Kurt H J ^a   Curran, John ^a   Olmstead, Charles ^a   Alger, Jeffrey R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; Low grade glioma; Magnetic resonance spectroscopy; Prognosis; Tumor

Indexed keywords

ARTICLE; CHILD; CLINICAL ARTICLE; DEVICE; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SCINTISCANNING; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ASPARTIC ACID; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CELL DIVISION; CHILD; CHILD, PRESCHOOL; CHOLINE; CREATINE; ENERGY METABOLISM; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 0031783102     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199810000-00053     Document Type: Article

References (54)

1. Aiken NR, Gillies RJ: Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors. Anti-cancer Res 16:1393-1397, 1996.
2. Bhakoo KK, Williams SR, Florian CL, Land H, Noble MD: Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res 56:4630-4635, 1996.
3. Campbell JW, Pollack IF, Martinez AJ, Shultz B: High-grade astrocytomas in children: Radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 38: 258-264, 1996.
4. 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 5:157-163, 1995.
5. Cuadrado A, Carnero A, Dolfi F, Jimenez B, Lacal JC: Phosphorylcholine, a novel second messenger essential for mitogenic activity. Oncogene 8:2959-2968, 1993.
6. Cunningham JM, Kimmel DW, Scheithauer BW, O'Fallon JR, Novotny PJ, Jenkins RB: Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value. J Neurosurg 86:121-130, 1997.
7. Davies SE, Newcombe J, Williams SR, McDonald WI, Clark JB: High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 64:742-748, 1995.
8. Decaestecker C, Salmon I, Dewitte O, Camby I, Van Ham P, Pasteels JL, Brotchi J, Kiss R: Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables. J Neurosurg 86:532-537, 1997.
9. De Witte O, Levivier M, Violon P, Salmon I, Damhaut P, Wikler D Jr, Hildebrand J, Brotchi J, Goldman S: Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 39:470-476, 1996.
10. Dropcho EJ, Soong SJ: The prognostic impact of prior low grade histology in patients with anaplastic gliomas: A case-control study. Neurology 47:684-690, 1996.
11. Felix CA, Slavc I, Dunn M, Strauss EA, Philips PC, Rorke LB, Sutton L, Bunin GR, Biegel JA: p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol 25:431-436, 1995.
12. Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, Di Chiro G: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185:675-686, 1992.
13. Garvey M, Packer RJ: An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol 28:167-183, 1996.
14. Gillies RJ, Barry JA, Ross BD: In vitro and in vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells. Magn Reson Med 32:310-318, 1994.
15. Go KG, Keuter EJ, Kamman RL, Pruim J, Metzemaekers JD, Staal MJ, Paans AM, Vaalburg W. Contribution of magnetic resonance spectroscopic imaging and L-[1-11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 34:994-1002, 1994.
16. Hagberg G, Burline AP, Mader I, Roser W, Radue EW, Seelig J: In vivo proton MR spectroscopy of human gliomas: Definition of metabolic coordinates for multidimensional classification. Magn Reson Med 34:242-252, 1995.
17. Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker LE, Jenkin D, Greenberg M: Optic pathway/hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 19:186-195, 1993.
18. Hoffman HJ, Soloniuk DS, Humphreys RP, Drake JM, Becker LE, De Lima BO, Piatt JH Jr: Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. Neurosurgery 33:964-971, 1993.
19. Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB: Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 53: 550-555, 1993.
20. Howe FA, Maxwell RJ, Saunders DE, Brown MM, Griffiths JR: Proton spectroscopy in vivo. Magn Reson Q 9:31-59, 1993.
21. Ito S, Hoshino T, Shibuya M, Prados MD, Edwards MS, Davis RL: Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling. Neurosurgery 31:413-419, 1992.
22. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT, Philips PC, Lance BJ: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051-1059, 1995.
23. Kinoshita Y, Kajiwara H, Yokota A, Koga Y: Proton magnetic resonance spectroscopy of brain rumors: An in vitro study. Neurosurgery 35:606-613, 1994.
24. 1H MRS of human brain tumor and normal glial cells. NMR Biomed 7:111-120, 1994.
25. Kugel H, Heindel W, Emestus RI, Bunke J, du Mesnil R, Friedmann G: Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183:701-709, 1992.
26. Lazareff JA, Olmstead C, Bockhorst KH, Alger JR: Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas. Childs Nerv Syst 12:130-135, 1996.
27. Lee YY, Van Tassel P, Bruner JM, Moser RP, Share JC: Juvenile pilocytic astrocytomas: CT and MR characteristics. Am J Roentgenol 152:1263-1270, 1989.
28. Leeds NE, Jackson EF: Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 6:254-261, 1994.
29. 1H magnetic resonance spectroscopy. Surg Neurol 44:137-144, 1995.
30. Meyerhoff DJ: Magnetic resonance spectroscopic imaging, in Gillies RJ (ed): NMR in Physiology and Biomedicine. San Diego, Academic Press, 1994, pp 169-184.
31. 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sci 58:1929-1935, 1996.
32. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Schaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman R: Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg 84:449-458, 1996.
33. Noble M, Gutowski N, Bevan K, Engel U, Linskey M, Urenjak J, Bhakoo K, Williams S: From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage. Glia 15:222-230, 1995.
34. Ott D, Hennig J, Ernst T: Human brain rumors: Assessment with in vivo proton MR spectroscopy. Radiology 186:745-752, 1993.
35. Packer RJ: Diagnosis and treatment of pediatric brain tumors. Curr Opin Neurol 7:484-491, 1994.
36. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deustch M: Low-grade gliomas of the cerebral hemispheres in children: An analysis of 71 cases. J Neurosurg 82:536-547, 1995.
37. Prados MD, Krouwer HG, Edwards MS, Cogen PH, Davis RL, Hoshino T: Proliferative potential and outcome in pediatric astrocytic tumors. J Neurooncol 13:277-282, 1992.
38. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325, 1996.
39. Rey JA, Pestana A, Bello MJ: Cytogenetics and molecular genetics of nervous system tumors. Oncol Res 4:321-331, 1992.
40. Salmon I, Dewitte O, Pasteels JL, Flament-Durand J, Brotchi J, Vereerstraeten P, Kiss R: Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. J Neurosurg 80:877-883, 1994.
41. Scerrati M, Roselli R, Iacoangeli M, Pomppucci A, Rossi GF: Prognostic factors in low grade (WHO Grade II) gliomas of the cerebral hemispheres: The role of surgery. J Neurol Neurosurg Psychiatry 61:291-296, 1996.
42. Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S, Yoshimoto T: Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 17:737-747, 1996.
43. Sutton LN, Molloy PT, Sernyak H, Goldwein J, Philips PL, Rorke LB, Moshang T Jr, Lange B, Packer PJ: Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 83:583-598, 1995.
44. Sutton LN, Wang Z, Gusnard D, Lange B, Perilongo G, Bogdan AR, Detre JA, Rorke L, Zimmerman RA: Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31:195-202, 1992.
45. 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J Neurosurg 81:443-448, 1994.
46. Tien RD, Lai PH, Smith JS, Lazeyras F: Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 167:201-209, 1996.
47. Tzika AA, Vigneron DB, Dunn RS, Nelson SJ, Ball WS Jr: Intracranial tumors in children: Small single-voxel proton MR spectroscopy using short- and long-echo sequences. Neuroradiology 38:254-263, 1996.
48. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989, 1993.
49. 1H-NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18:705-713, 1994.
50. 1H NMR spectroscopy in vivo and in vitro. J Neurochem 63:1538-1543, 1994.
51. Vigliani MC, Chiò A, Pezzulo T, Soffietti R, Giordana MT, Schiffer D: Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: Its prognostic significance. Tumori 80:295-300, 1994.
52. Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW: What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 24:354-371, 1994.
53. Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA: Proton MR spectroscopy of pediatric cerebellar rumors. AJNR Am J Neuroradiol 16:1821-1833, 1995.
54. Wilkinson L: SYSTAT: The System for Statistics. Evanston, SYSTAT, Inc., 1990.